A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
// Ilaria Sciamanna 1 , Alberto Gualtieri 1,5 , Cristina Cossetti 1,5 , Emanuele Felice Osimo 1 , Manuela Ferracin 2 , Gianfranco Macchia 1 , Eleonora Aricò 1 , Gianni Prosseda 3 , Patrizia Vitullo 1 , Tom Misteli 4 and Corrado Spadafora 1 1 Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy. 2 Laboratory for Technologies of Advanced Therapies (LTTA) and Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy. 3 Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, Rome, Italy. 4 National Cancer Institute, NIH, Bethesda MD, USA. 5 Department of Experimental Medicine and Surgery - University of Rome “Tor Vergata”, Rome, Italy. Correspondence: Corrado Spadafora, email: // Keywords : LINE-1 retrotransposons, reverse transcriptase, transcriptome, miRNAs, DNA:RNA hybrids, cancer genome, reverse transcriptase inhibitor. Received : September 11, 2013 Accepted : October 12, 2013 Published : October 14, 2013 Abstract LINE-1 elements make up the most abundant retrotransposon family in the human genome. Full-length LINE-1 elements encode a reverse transcriptase (RT) activity required for their own retrotranpsosition as well as that of non-autonomous Alu elements. LINE-1 are poorly expressed in normal cells and abundantly in cancer cells. Decreasing RT activity in cancer cells, by either LINE-1-specific RNA interference, or by RT inhibitory drugs, was previously found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Here we have investigated how RT exerts these global regulatory functions. We report that the RT inhibitor efavirenz (EFV) selectively downregulates proliferation of transformed cell lines, while exerting only mild effects on non-transformed cells; this differential sensitivity matches a differential RT abundance, which is high in the former and undetectable in the latter. Using CsCl density gradients, we selectively identify Alu and LINE-1 containing DNA:RNA hybrid molecules in cancer but not in normal cells. Remarkably, hybrid molecules fail to form in tumor cells treated with EFV under the same conditions that repress proliferation and induce the reprogramming of expression profiles of coding genes, microRNAs (miRNAs) and ultraconserved regions (UCRs). The RT-sensitive miRNAs and UCRs are significantly associated with Alu sequences. The results suggest that LINE-1-encoded RT governs the balance between single-stranded and double-stranded RNA production. In cancer cells the abundant RT reverse-transcribes retroelement-derived mRNAs forming RNA:DNA hybrids. We propose that this impairs the formation of double-stranded RNAs and the ensuing production of small regulatory RNAs, with a direct impact on gene expression. RT inhibition restores the ‘normal’ small RNA profile and the regulatory networks that depend on them. Thus, the retrotransposon-encoded RT drives a previously unrecognized mechanism crucial to the transformed state in tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Ultraconserved Elements in the Human Genome
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., & Haussler, D. (2004) · Science · doi:10.1126/science.1098119 · Cited by 1,732
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos
Peaston, A. E., Evsikov, A. V., Graber, J. H., de Vries, W. N., Holbrook, A. E., Solter, D., & Knowles, B. B. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.004 · Cited by 710
Kapusta, A., Kronenberg, Z., Lynch, V. J., Zhuo, X., Ramsay, L., Bourque, G., Yandell, M., & Feschotte, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003470 · Cited by 687
Mobile elements and mammalian genome evolution
Deininger, P. L., Moran, J. V., Batzer, M. A., & Kazazian, H. H. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.10.013 · Cited by 479 · cited 1×
“LINE-1-encoded RT catalyzes the reverse transcription of both LINE-1 and Alu RNAs as a key step in the process of retrotransposition [29].”
BackgroundDai, L., Huang, Q., & Boeke, J. D. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-18 · Cited by 131 · cited 1×
“Efavirenz (EFV), a non-nucleoside RT inhibitor originally designed to target the HIV-encoded RT, has a demonstrated ability to inhibit the endogenous cellular RT [24]; remarkably, EFV elicits the same cancer reversal phenotypes [22, 23, 25] observed after RNAi silencing of active LINE-1 elements [23, 26].”
BackgroundMany LINE1 elements contribute to the transcriptome of human somatic cells
Rangwala, S. H., Zhang, L., & Kazazian, H. H. (2009) · Genome Biology · doi:10.1186/gb-2009-10-9-r100 · Cited by 102 · cited 1×
“Both families influence the transcriptional output of the genome and growing studies highlight roles of both families in tumorigenesis [6-8].”
BackgroundCell Divisions Are Required for L1 Retrotransposition
Shi, X., Seluanov, A., & Gorbunova, V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01888-06 · Cited by 93
Cited by
Jin, Y., Tam, O. H., Paniagua, E., & Hammell, M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv422 · Cited by 737
Roles for retrotransposon insertions in human disease
Hancks, D. C., & Kazazian, H. H. (2016) · Mobile DNA · doi:10.1186/s13100-016-0065-9 · Cited by 670
“In addition, ORF2p expression may have important roles in cancer onset and progression through perturbation of regulatory networks [217–220].”
BackgroundRestricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons
Liu, E. Y., Russ, J., Cali, C. P., Phan, J. M., Amlie-Wolf, A., & Lee, E. B. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.003 · Cited by 231
“expression of repetitive genomic elements (De Cecco et al., 2019; Lin et al., 2009; Sciamanna et al., 2013).”
Metadata
- Authors
- Sciamanna, I., Gualtieri, A., Cossetti, C., Osimo, E. F., Ferracin, M., Macchia, G., Aricò, E., Prosseda, G., Vitullo, P., Misteli, T., & Spadafora, C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2013-10-14
- Volume
- 4
- Issue
- 12
- Pages
- 2271-2287
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2157488233
- Cited by
- 47
- References
- 10
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.